News on Projects | India - Drugs & Pharma - New projects information in India, Middle East, South Asia

Lyfius Pharma has officially inaugurated its advanced Penicillin-G (Pen-G) manufacturing facility in Kakinada, Andhra Pradesh, boasting an annual production capacity of 15,000 metric tonnes (MT). The facility was virtually inaugurated... Full Story

Piramal Alternatives Injects ₹110 Crore into Biodeal Pharmaceuticals

Piramal Alternatives has announced a substantial investment of ₹110 crore in Biodeal Pharmaceuticals Ltd, a prominent contract development and manufacturing... Full Story

Browse All News by Date

Gland Pharma to invest ₹400 crore for expanding Hyderabad capacity.

Gland Pharma will be investing over ₹400 crore in adding up capabilities to their existing facility in the Genome Valley he to... Full Story

More General Stories

LATEST HEADLINES FROM MIDDLE EAST AND NORTH AFRICA

"Two-Thirds of Greenfield Units Under PLI Scheme for Bulk Drugs Completed"
According to a senior government official, nearly two-thirds of all greenfield plants planned under the production-linked incentive (PLI) scheme for bulk drugs and medical devices... Full Story
"Rusan Pharma Allocates INR 300 Crores for New API Facility in Pithampur, Madhya Pradesh"
Pithampur, Madhya Pradesh, witnessed the inauguration of Rusan Pharma's state-of-the-art active pharmaceutical ingredient (API) facility recently. The pharmaceutical company has invested Rs. 300 crore in... Full Story
Pharmacies to be set up at 270 stations in Eastern Railway zone: Official.
Healthcare facilities such as pharmacies and collection centres for pathology laboratories will be established at 270 stations in the Eastern Railway zone by the end... Full Story
Solara receives EDQM CEP approval for its API unit in Vishakhapatnam.
Solara Active Pharma Sciences announced that its new state of the art multipurpose API manufacturing facility at Vishakhapatnam, Andhra Pradesh, had received 'Certificate of Suitability'... Full Story
IIL to set up new animal vaccine unit in Hyderabad at ₹700 cr.
Indian Immunologicals Limited (IIL) will invest about ₹700 crore in setting up a new animal vaccine manufacturing facility in Genome Valley, Hyderabad. The new plant... Full Story
Lincoln Pharmaceuticals acquires Cephalosporin plant in Mehsana.
Lincoln Pharmaceuticals Limited recently announced the acquisition of a Cephalosporin manufacturing plant in Mehsana. Lincoln will launch Cephalosporin products - antibiotics - soon, it said. The company plans to... Full Story
Torrent acquires Elder unit for Rs. 2,000 crore.
Ahmedabad-based Torrent is set to acquire Mumbai-based Elder Pharma's entire domestic formulations business in India and Nepal for Rs. 2,004 crore, making it the first... Full Story
Intas Pharma is planning to raise R2. 50Cr PE investment for expansion
Intas Pharma is planning to raise R250Cr private equity investment for expansion. Intas Pharma filed DRHP to raise upto R425Cr through fresh issue of shares. The company... Full Story